Fluad Injection, Suspension
Product Images NDC 70461-025

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Fluad (NDC 70461-025). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Seqirus, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Flu2e 0013 01

This text provides detailed information about the FLUAD influenza vaccine for the 2024 - 2025 season. The vaccine is adjuvanted and specifically targeted for adults aged 65 years and older. Each 0.5 mL dose contains three recommended influenza strains along with an oikin-water emulsion adjuvant. The vaccine does not contain preservatives and should be stored between 2'-8'C. The manufacturing and distribution details are also included. Overall, this information is useful for individuals seeking information about the FLUAD vaccine for the specified season.*

FDA Label Image

Flu2e 0013 02

This is a 0.5 mL dose intended for intramuscular use in adults aged 65 years and older. Manufactured by Seqirus Inc. under US License No. 2049.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.